Global Health Ltd (MEDANTA) Q4FY26 Concall Summary - Mar-2026 Qtr
Performance Overview
- The company achieved its highest-ever quarterly revenue and EBITDA, demonstrating strong operational momentum across its hospital network.
- Performance was driven by a significant increase in patient volumes, with inpatient counts growing 16% and outpatient counts by 19% year-on-year, coupled with healthy occupancy levels.
- The newly launched Noida hospital showed a promising ramp-up, with its quarterly EBITDA loss narrowing from INR 320 million in Q3 to INR 236 million in Q4, indicating a clear path towards profitability.
- The developing hospitals portfolio (excluding Noida) continued its strong growth trajectory, with revenue increasing by 29% and EBITDA by 35% year-on-year, showcasing successful scaling and efficiency improvements.
- The company maintained a robust financial position, ending the fiscal year with a net cash position of INR 5,906 million, providing substantial flexibility to fund its aggressive expansion pipeline of approximately 2,700 beds over the next 3-4 years.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.